These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

105 related articles for article (PubMed ID: 6328115)

  • 1. Neutrophil dysfunction in sepsis. III. Degranulation as a mechanism for nonspecific deactivation.
    Solomkin JS; Cotta LA; Brodt JK; Hurst JW; Ogle CK
    J Surg Res; 1984 May; 36(5):407-12. PubMed ID: 6328115
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Neutrophil dysfunction in sepsis. II. Evidence for the role of complement activation products in cellular deactivation.
    Solomkin JS; Jenkins MK; Nelson RD; Chenoweth D; Simmons RL
    Surgery; 1981 Aug; 90(2):319-27. PubMed ID: 7256544
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Human neutrophil Fc gamma RIIIB and formyl peptide receptors are functionally linked during formyl-methionyl-leucyl-phenylalanine-induced chemotaxis.
    Kew RR; Grimaldi CM; Furie MB; Fleit HB
    J Immunol; 1992 Aug; 149(3):989-97. PubMed ID: 1321856
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Complement activation and clearance in acute illness and injury: evidence for C5a as a cell-directed mediator of the adult respiratory distress syndrome in man.
    Solomkin JS; Cotta LA; Satoh PS; Hurst JM; Nelson RD
    Surgery; 1985 Jun; 97(6):668-78. PubMed ID: 4002115
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Decreased extracellular release of granule enzymes from in vitro-stimulated polymorphonuclear leukocytes in guttate psoriasis.
    Glinski W; Tigalonowa M; Jablonska S; Janczura E
    Inflammation; 1986 Jun; 10(2):99-108. PubMed ID: 3710563
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Regulation of neutrophil superoxide production in sepsis.
    Solomkin JS; Cotta LA; Brodt JK; Hurst JM
    Arch Surg; 1985 Jan; 120(1):93-8. PubMed ID: 2981524
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Chemotactic peptide binding by intact neutrophils from human neonates.
    Strauss RG; Snyder EL
    Pediatr Res; 1984 Jan; 18(1):63-6. PubMed ID: 6322097
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Effects of pepstatin A on neutrophils; cross-deactivation with FMLP].
    Muniain MA; Pozuelo F; Pérez-Venegas JJ; Romero-Tabares A; Rodríguez-Hornillo MC; Garrido M
    Rev Esp Fisiol; 1985 Mar; 41(1):125-31. PubMed ID: 2988085
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Selective inhibition by phenytoin of chemotactic factor - stimulated neutrophil functions.
    Webster RO; Goldstein IM; Flick MR
    J Lab Clin Med; 1984 Jan; 103(1):22-33. PubMed ID: 6317777
    [TBL] [Abstract][Full Text] [Related]  

  • 10. In vivo and in vitro assessment of porcine neutrophil activation responses to chemoattractants: flow cytometric evidence for the selective absence of formyl peptide receptors.
    Fletcher MP; Stahl GL; Longhurst JC
    J Leukoc Biol; 1990 Apr; 47(4):355-65. PubMed ID: 2108228
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Phorbol myristate acetate enhances human polymorphonuclear neutrophil release of granular enzymes but inhibits chemokinesis.
    Hoult JR; Nourshargh S
    Br J Pharmacol; 1985 Nov; 86(3):533-7. PubMed ID: 4063581
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The effect of storage on degranulation by human neutrophils.
    Lane TA; Lamkin GE
    Transfusion; 1985; 25(2):155-61. PubMed ID: 3984010
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Differential inhibition of human neutrophil activation by cyclosporins A, D, and H. Cyclosporin H is a potent and effective inhibitor of formyl peptide-induced superoxide formation.
    Wenzel-Seifert K; Grünbaum L; Seifert R
    J Immunol; 1991 Sep; 147(6):1940-6. PubMed ID: 1653806
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Leukocyte inhibitory factor (LIF) potentiates neutrophil responses to formyl-methionyl-leucyl-phenylalanine.
    Borish L; O'Reilly D; Klempner MS; Rocklin RE
    J Immunol; 1986 Sep; 137(6):1897-903. PubMed ID: 3018081
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Protective effect of indomethacin against chemotactic deactivation of human neutrophils induced by formylated peptide.
    Perianin A; Gaudry M; Marquetty C; Giroud JP; Hakim J
    Biochem Pharmacol; 1988 May; 37(9):1693-8. PubMed ID: 2837237
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The effects of adenosine agonists on human neutrophil function.
    Schrier DJ; Imre KM
    J Immunol; 1986 Nov; 137(10):3284-9. PubMed ID: 3021850
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Inhibition of human neutrophil receptor-mediated uptake of N-formyl-met-leu-phe by platelet factor 4 (59-70).
    Goldman DW; Hannah AL; Goetzl EJ
    Immunology; 1985 Jan; 54(1):163-72. PubMed ID: 3838292
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Priming induces functional coupling of N-formyl-methionyl-leucyl-phenylalanine receptors in equine neutrophils.
    Brazil TJ; Rossi AG; Haslett C; McGorum B; Dixon PM; Chilvers ER
    J Leukoc Biol; 1998 Mar; 63(3):380-8. PubMed ID: 9500527
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Signal transduction in human alveolar macrophages: diminished chemotactic response to FMLP correlates with a diminished density of Gi proteins and FMLP receptors.
    Beaty CD; Martin TR; Wilson CB
    Am J Respir Cell Mol Biol; 1991 Jul; 5(1):87-92. PubMed ID: 1908689
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Altered polymorphonuclear leukocyte responses in psoriasis: chemotaxis and degranulation.
    Preissner WC; Schröder JM; Christophers E
    Br J Dermatol; 1983 Jul; 109(1):1-8. PubMed ID: 6860565
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.